Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival.

Abstract:

:Surgery remains the only chance of cure for pancreatic cancer, but only 15%-25% of patients present with resectable disease at the time of primary diagnosis. Important goals in clinical research must therefore be to allow early detection with suitable diagnostic procedures, to further broaden operation techniques and to determine the most effective perioperative treatment of either chemotherapy and/or radiation therapy. More extensive operations involving extended pancreatectomy, portal vein resection and pancreatic resection in resectable pancreatic cancer with limited liver metastasis, performed in specialized centers seem to be the surgical procedures with a possible impact on survival. After many years of stagnation in pharmacological clinical research on advanced pancreatic ductal adenocarcinomas (PDAC) - since the approval of gemcitabine in 1997 - more effective cytotoxic substances (nab-paclitaxel) and combinations (FOLFIRINOX) are now available for perioperative treatment. Additionally, therapies with a broader mechanism of action are emerging (stroma depletion, immunotherapy, anti-inflammation), raising hopes for more effective adjuvant and neoadjuvant treatment concepts, especially in the context of "borderline resectability". Only multidisciplinary approaches including radiology, surgery, medical and radiation oncology as the backbones of the treatment of potentially resectable PDAC may be able to further improve the rate of cure in the future.

authors

Sinn M,Bahra M,Denecke T,Travis S,Pelzer U,Riess H

doi

10.4251/wjgo.v8.i3.248

subject

Has Abstract

pub_date

2016-03-15 00:00:00

pages

248-57

issue

3

issn

1948-5204

journal_volume

8

pub_type

杂志文章,评审
  • Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.

    abstract:BACKGROUND:Bile duct cancer constitutes gallbladder cancer (GBC), intrahepatic cholangiocarcinoma (ICA), and extrahepatic cholangiocarcinoma (ECA). These three entities show morphological and immunohistochemical resemblance so that it is difficult to differentiate between primary ICA and liver metastasis of GBC, which ...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v11.i9.761

    authors: Inagaki C,Maeda D,Kimura A,Otsuru T,Iwagami Y,Nishida N,Sakai D,Shitotsuki R,Yachida S,Doki Y,Satoh T

    更新日期:2019-09-15 00:00:00

  • Current strategies for malignant pedunculated colorectal polyps.

    abstract::Despite significant advances in imaging techniques, the incidence of colorectal cancer has been increasing in recent years, with many cases still being diagnosed in advanced stages. Early detection and accurate staging remain the main factors that lead to a decrease in the cost and invasiveness of the curative techniq...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i12.465

    authors: Ciocalteu A,Gheonea DI,Saftoiu A,Streba L,Dragoescu NA,Tenea-Cojan TS

    更新日期:2018-12-15 00:00:00

  • Endoscopic electronic record: A new approach for improving management of colorectal cancer prevention.

    abstract::Digestive endoscopy is currently the main diagnostic procedure for investigation of the digestive tract when a digestive disease is suspected. The use of computers and electronic medical records for the management of endoscopic data are an important key to improving endoscopy unit efficiency and productivity. This tec...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v4.i4.76

    authors: Maserat E,Safdari R,Maserat E,Zali MR

    更新日期:2012-04-15 00:00:00

  • Genetic risks and familial associations of small bowel carcinoma.

    abstract::Adenocarcinoma of small intestines (SBA) is a relatively rare malignancy with poor outcomes due to delayed diagnosis. Fifty percent of patients have metastases on presentation and therefore early detection and treatment offers the best long term outcomes. Certain genetic polyposis syndromes and familial diseases are a...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i6.509

    authors: Shenoy S

    更新日期:2016-06-15 00:00:00

  • Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

    abstract::Standard pancreatic resections, such as pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy, result in an important loss of normal pancreatic parenchyma and may cause impairment of exocrine and endocrine function. Whilst these procedures are mandatory for malignant tumors, they seem to be too exten...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i6.272

    authors: Sperti C,Beltrame V,Milanetto AC,Moro M,Pedrazzoli S

    更新日期:2010-06-15 00:00:00

  • Targeted agents for second-line treatment of advanced hepatocellular carcinoma.

    abstract::Over the past ten years, sorafenib, a multikinase inhibitor, has been the standard of care for patients with unresectable hepatocellular carcinoma (HCC) and well-preserved liver function. Recently, lenvatinib, a different multikinase inhibitor, was shown to be non-inferior to sorafenib, in terms of survival, while all...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v11.i10.788

    authors: Personeni N,Pressiani T,Bozzarelli S,Rimassa L

    更新日期:2019-10-15 00:00:00

  • Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

    abstract::Pancreatic cancer, with a 5% 5-year survival rate, is the fourth leading cause of cancer death in Western countries. Unfortunately, only 20% of all patients benefit from surgical treatment. The need to prolong survival has prompted pathologists to develop improved protocols to evaluate pancreatic specimens and their s...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v6.i9.351

    authors: Gómez-Mateo Mdel C,Sabater-Ortí L,Ferrández-Izquierdo A

    更新日期:2014-09-15 00:00:00

  • Emerging molecular targets and therapy for cholangiocarcinoma.

    abstract::Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and limited therapeutic options. Recent large scale molecular characterisation studies have identified recurrent genetic alterations in CCA which may be amenable to therapeutic targeting. In this review we explore the genomic...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v9.i7.268

    authors: Kayhanian H,Smyth EC,Braconi C

    更新日期:2017-07-15 00:00:00

  • Epigenetic reduction of DNA repair in progression to gastrointestinal cancer.

    abstract::Deficiencies in DNA repair due to inherited germ-line mutations in DNA repair genes cause increased risk of gastrointestinal (GI) cancer. In sporadic GI cancers, mutations in DNA repair genes are relatively rare. However, epigenetic alterations that reduce expression of DNA repair genes are frequent in sporadic GI can...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i5.30

    authors: Bernstein C,Bernstein H

    更新日期:2015-05-15 00:00:00

  • Epigenetic field defects in progression to cancer.

    abstract::A field defect is a field of pre-malignant tissue in which a new cancer is likely to arise. Field defects often appear to be histologically normal under the microscope. Recent research indicates that cells within a field defect characteristically have an increased frequency of epigenetic alterations and these may be f...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v5.i3.43

    authors: Bernstein C,Nfonsam V,Prasad AR,Bernstein H

    更新日期:2013-03-15 00:00:00

  • Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review.

    abstract::Colorectal carcinogenesis (CRC) imposes a major health burden in developing countries. It is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs are warranted to reduce the severity of this disease. Adenomatous polyps in the colon are the major culprits in CRC and found in 45% of ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i9.244

    authors: Pandurangan AK,Divya T,Kumar K,Dineshbabu V,Velavan B,Sudhandiran G

    更新日期:2018-09-15 00:00:00

  • Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

    abstract::Pancreatic adenocarcinoma is the fourth cause of cancer-related death in the United States. Surgery is the only potentially curative treatment, but most patients present at diagnosis with unresectable or metastatic disease. Moreover, even with an R0 resection, the majority of patients will die of disease recurrence. M...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i12.375

    authors: Sperti C,Moletta L,Merigliano S

    更新日期:2015-12-15 00:00:00

  • Current status of robot-assisted gastric surgery.

    abstract::In an effort to minimize the limitations of laparoscopy, a robotic surgery system was introduced, but its role for gastric cancer is still unclear. The objective of this article is to assess the current status of robotic surgery for gastric cancer and to predict future prospects. Although the current study was limited...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v3.i10.137

    authors: Baek SJ,Lee DW,Park SS,Kim SH

    更新日期:2011-10-15 00:00:00

  • Tumor stem cell, or its niche, which plays a primary role in tumorigenesis?

    abstract::Cancer research over the past decades has focused on neoplastic cells, or a fraction of them, i.e. tumor stem cells, as the ultimate causes of tumorigenesis. However, during recent years, scientists have come to realize that tumorigenesis is not a solo act of neoplastic cells, but rather a cooperative process in which...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i5.218

    authors: Zhu J,Ding J,Ding F

    更新日期:2010-05-15 00:00:00

  • Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

    abstract::Most patients treated with curative intent for colorectal cancer (CRC) are included in a follow-up program involving periodic evaluations. The survival benefits of a follow-up program are well delineated, and previous meta-analyses have suggested an overall survival improvement of 5%-10% by intensive follow-up. Howeve...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v6.i5.104

    authors: Augestad KM,Rose J,Crawshaw B,Cooper G,Delaney C

    更新日期:2014-05-15 00:00:00

  • Three novel NEIL1 promoter polymorphisms in gastric cancer patients.

    abstract:AIM:To identify genetic polymorphisms in the promoter region of the human base excision repair gene NEIL1 in gastric cancer patients. METHODS:The NEIL1 promoter region in DNA from 80 Japanese patients with gastric cancer was searched for genetic polymorphisms by polymerase chain reaction-single-strand conformation pol...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i2.117

    authors: Goto M,Shinmura K,Tao H,Tsugane S,Sugimura H

    更新日期:2010-02-15 00:00:00

  • Adenocarcinoma of the small bowel in a patient with occlusive Crohn's disease.

    abstract::A 40-year-old male, diagnosed with mild Crohn's disease (CD) 11 years ago but with no prior abdominal surgeries, was diagnosed with a small bowel stricture, due to ongoing abdominal pain and intolerance of enteral diet, and referred for surgical treatment. Exploratory laparoscopy revealed a white solid mass causing a ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v4.i7.184

    authors: Drukker L,Edden Y,Reissman P

    更新日期:2012-07-15 00:00:00

  • Novel therapeutic agents in the treatment of metastatic colorectal cancer.

    abstract::Over the past couple of decades considerable progress has been made in the management of metastatic colorectal cancers (mCRC) leading to a significant improvement in five-year survival. Although part of this success has been rightly attributed to aggressive surgical management and advances in other adjunct treatments,...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i1.99

    authors: Pai SG,Fuloria J

    更新日期:2016-01-15 00:00:00

  • Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy.

    abstract:BACKGROUND:Neoadjuvant chemotherapy has been applied worldwide to improve the survival of patients with gastric adenocarcinoma (GAC). The evaluation of histological regression in primary tumors is valuable for predicting prognosis. However, the prognostic effect of regression change in lymph nodes (LNs) remains unclear...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v11.i1.48

    authors: Zhu YL,Sun YK,Xue XM,Yue JY,Yang L,Xue LY

    更新日期:2019-01-15 00:00:00

  • Prognostic scoring system for synchronous brain metastasis at diagnosis of colorectal cancer: A population-based study.

    abstract:BACKGROUND:Brain metastasis (BM) from colorectal cancer (CRC) is rarely encountered clinically, and its prognosis has not been fully evaluated. AIM:To construct a scoring system and accurately predict the survival of patients with synchronous BM at diagnosis of CRC. METHODS:A retrospective study of 371 patients with ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i2.195

    authors: Quan JC,Guan X,Ma CX,Liu Z,Yang M,Zhao ZX,Sun P,Zhuang M,Wang S,Jiang Z,Wang XS

    更新日期:2020-02-15 00:00:00

  • Gastrointestinal neuroendocrine tumors in 2020.

    abstract::Gastrointestinal neuroendocrine tumors are rare slow-growing tumors with distinct histological, biological, and clinical characteristics that have increased in incidence and prevalence within the last few decades. They contain chromogranin A, synaptophysin and neuron-specific enolase which are necessary for making a d...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v12.i8.791

    authors: Ahmed M

    更新日期:2020-08-15 00:00:00

  • Pathological aspects of so called "hilar cholangiocarcinoma".

    abstract::Cholangiocarcinoma (CC) arising from the large intrahepatic bile ducts and extrahepatic hilar bile ducts share clinicopathological features and have been called hilar and perihilar CC as a group. However, "hilar and perihilar CC" are also used to refer exclusively to the intrahepatic hilar type CC or, more commonly, t...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v5.i7.159

    authors: Castellano-Megías VM,Ibarrola-de Andrés C,Colina-Ruizdelgado F

    更新日期:2013-07-15 00:00:00

  • Precision medicine for gastrointestinal cancer: Recent progress and future perspective.

    abstract::Gastrointestinal (GI) cancer has a high tumor incidence and mortality rate worldwide. Despite significant improvements in radiotherapy, chemotherapy, and targeted therapy for GI cancer over the last decade, GI cancer is characterized by high recurrence rates and a dismal prognosis. There is an urgent need for new diag...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v12.i1.1

    authors: Matsuoka T,Yashiro M

    更新日期:2020-01-15 00:00:00

  • Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer - 5-year follow up.

    abstract:BACKGROUND:Rectal cancer (RC) is one of the most common diagnosed cancers, and one of the major causes of cancer-related death nowadays. Majority of the current guidelines rely on TNM classification regarding therapy regiments, however recent studies suggest that additional histopathological findings could affect the d...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i5.592

    authors: Stojkovic Lalosevic M,Milovanovic T,Micev M,Stojkovic M,Dragasevic S,Stulic M,Rankovic I,Dugalic V,Krivokapic Z,Pavlovic Markovic A

    更新日期:2020-05-15 00:00:00

  • Paraneoplastic leukemoid reaction in pancreatic cancer: A case report.

    abstract::Paraneoplastic leukemoid reaction is a rare syndrome defined by a leukocyte count exceeding 50 Giga/Liter (G/L), mostly described with progressive lung or renal carcinoma. We report a case of a 68-year-old man with recurrent pancreatic carcinoma presenting a leukemoid reaction with a white blood cell count of 63.87 G/...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v7.i10.259

    authors: Dos Santos M,Bouhier K,Dao MT

    更新日期:2015-10-15 00:00:00

  • Status of colitis-associated cancer in ulcerative colitis.

    abstract::Surgical therapy for ulcerative colitis (UC) depends on the medical therapy administered for the patient's condition. UC is a benign disease. However, it has been reported that the rare cases of cancer in UC patients are increasing, and such cases have a worse prognosis. Recently, surgical therapy has greatly changed,...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i4.351

    authors: Kinugasa T,Akagi Y

    更新日期:2016-04-15 00:00:00

  • Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.

    abstract:AIM:To examine survival outcomes of perihilar cholangiocarcinoma (PCCA) resection including mortality, morbidity and prognostic factors. METHODS:Multivariate analyses were carried out based on the survival data of all patients with histologically confirmed PCCA who underwent curative resection at Srinagarind Hospital ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i12.503

    authors: Titapun A,Pugkhem A,Luvira V,Srisuk T,Somintara O,Saeseow OT,Sripanuskul A,Nimboriboonporn A,Thinkhamrop B,Khuntikeo N

    更新日期:2015-12-15 00:00:00

  • Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma.

    abstract:BACKGROUND:Overexpression of SQSTM1 (sequestosome 1, P62) and nuclear factor-κB (NF-κB) plays an important role in the invasion and metastasis of a variety of malignant tumors. AIM:To explore the expression of P62 and NF-κB in pancreatic cancer and their relationship with clinicopathological features. METHODS:The exp...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i7.719

    authors: Zhang ZY,Guo S,Zhao R,Ji ZP,Zhuang ZN

    更新日期:2020-07-15 00:00:00

  • Ileal inflammatory fibroid polyp causing chronic ileocolic intussusception and mimicking cecal carcinoma.

    abstract::Inflammatory fibroid polyp (IFP) is a rare, idiopathic pseudotumorous lesion of the gastrointestinal tract. While mostly reported as solitary gastric lesions, multiple cases of small bowel IFPs are also reported. It is a documented cause of intussusception in adults. In the case reports of ileal inflammatory fibroid p...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v1.i1.89

    authors: Gara N,Falzarano JS,Limm WM,Namiki TS,Tom LK

    更新日期:2009-10-15 00:00:00

  • C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group.

    abstract:BACKGROUND:Long non-coding RNAs (lncRNAs) are a kind of single-stranded RNA of more than 200 nucleotides in length and have no protein-coding function. Amounting studies have indicated that lncRNAs could play a vital role in the initiation and development of cancers, including gastric cancer (GC). Considering the cruci...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v11.i2.139

    authors: Komaç Ö,Bengi G,Sağol Ö,Akarsu M

    更新日期:2019-02-15 00:00:00